Linkopings Universitet
- Address
- Sandbacksgatan 7, Linkopings Domkyrkofors., 582 25 Linköping, Sweden
Linkopings Universitet - Oncology Research Center
Linkopings Universitet is a prominent research institution conducting advanced clinical trials in oncology and hematological malignancies. The center demonstrates expertise in evaluating novel therapeutic combinations and treatment strategies for challenging cancers, with a particular focus on optimizing patient outcomes through innovative trial designs and precision medicine approaches.
- Gynecological oncology including metastatic, persistent, and recurrent cervical carcinoma
- Hematological malignancies with emphasis on multiple myeloma and minimal residual disease assessment
- Pancreatic cancer treatment optimization including neoadjuvant and adjuvant chemotherapy strategies
The center's research portfolio encompasses cutting-edge immunotherapy combinations with targeted agents such as atezolizumab and bevacizumab, advanced minimal residual disease monitoring using multiparametric flow cytometry in transplant-eligible patients, and innovative surgical approaches for pancreatic malignancies. Their trials emphasize critical endpoints including progression-free survival and overall survival, reflecting a commitment to improving long-term outcomes for patients with solid tumors and blood cancers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Navamedic AB1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Linkopings Universitet
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| An Observational Study of the Efficacy and Usability of OraFID Dispensing Device and Digital Application for Carbidopa and Levodopa Administration in Parkinson's Disease Patients | Navamedic AB | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atezolizumab | 1 | Unknown | 2018-10-02 | 2018-10-02 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.